Who has invested in iVIEW Therapeutics?

BioAdvance, Proxima Ventures are named among the investors backing iVIEW Therapeutics.

iVIEW Therapeutics Funding: $31M Raised, Series B (2024)

iVIEW Therapeutics funding overview

iVIEW Therapeutics is based in Plainsboro. iVIEW Therapeutics has raised $31M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2024. The round record for iVIEW Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include BioAdvance, Proxima Ventures. 2 distinct backers are named across the disclosed rounds.

iVIEW Therapeutics at a glance

Total raised: $31M
Latest round: Series B
Latest round date: May 2024
Headquarters: Plainsboro
Notable investors: BioAdvance, Proxima Ventures

Frequently asked about iVIEW Therapeutics funding

How much has iVIEW Therapeutics raised?: iVIEW Therapeutics has raised $31M in total disclosed funding across the rounds on record.
Who has invested in iVIEW Therapeutics?: BioAdvance, Proxima Ventures are named among the investors backing iVIEW Therapeutics.
What was the latest iVIEW Therapeutics funding round?: The most recent disclosed round is a Series B, announced in May 2024.
Where is iVIEW Therapeutics based?: iVIEW Therapeutics is based in Plainsboro.
When did iVIEW Therapeutics last raise?: The last disclosed iVIEW Therapeutics round closed in May 2024 at Series B.

iVIEW Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Plainsboro below to benchmark round size and investor mix.

iVIEW Therapeutics Funding: $31M Raised, Series B (2024)

iVIEW Therapeutics funding overview

iVIEW Therapeutics at a glance

Frequently asked about iVIEW Therapeutics funding

Companies related to iVIEW Therapeutics (33)

Browse related funding lists (3)